Improving the Accuracy of Revised Cardiac Risk Index With HbA1C:Hemoglobin Ratio (HH Ratio)

NCT05066386 | Completed

• 1 other identifier: H-HHRatio-RCRI
• Study Type: observational
• Target: 20,099
• Locations: 0 countries
• Sites: N/A

Brief Summary

Retrospective observational study on the effects of altering components of RCRI to improve the predictive capacity.

Conditions

Risk Stratification; Perioperative Medicine

Keywords

HbA1C: Hemoglobin ratio (HH ratio); Risk model; RCRI

Outcome Measures

Primary Outcomes (1)

• Mortality

  To compare the predictive value of RCRI and substitution of the "DM on insulin" component with HH ratio for 30- and 90-day mortality

  90 days

Secondary Outcomes (1)

• Morbidity

  7 days

Interventions

Modified RCRI risk stratification OTHER

The objective of the study is to compare the predictive value of RCRI and substitution of the "DM on insulin" component with HH ratio for 30- and 90-day mortality, and postoperative acute myocardial injury(AMI) and acute kidney injury(AKI).

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

All patients undergoing non cardiac surgery in Singapore General Hospital

You may not qualify if:

• If patient is below 18 years old
• no History of DM
• No HbA1C done within 3 months prior to date of surgery

Sponsors & Collaborators

• Singapore General Hospital: lead

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: OTHER
• Target Duration: 3 Months
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: September 20, 2021
• First Posted: October 4, 2021
• Study Start: January 1, 2013
• Primary Completion: July 1, 2021
• Study Completion: August 1, 2021
• Last Updated: October 4, 2021

Record last verified: 2021-10

Data Sharing

• IPD Sharing: Will not share